- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Vera wraps up $80m series C
Vera has picked up series C cash from investors including GV and Alexandria Venture Investments to help progress its Merck Group-licensed autoimmune disease drug candidate through clinical trials.
Jan 22, 2021BlueNalu reels in $60m debt financing
Rich Products, Thai Union and OurCrowd have participated in a new round of convertible note financing for BlueNalu, which is developing lab-grown seafood products.
Jan 22, 2021Daily deal net: January 22, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jan 22, 2021KeraCel prints $14m in series A round
Musashi Seimitsu Industry has led a round that will support development of a proof-of-concept for KeraCel's 3D printing technology.
Jan 22, 2021Aerobotics adds series B funding
Naspers Foundry led a $17m round for Aerobotics, a developer of tree-health monitoring technology, having invested last May.
Jan 22, 2021Better Collective bets on Mindway AI
Founded out of Aarhus University in 2004, Mindway AI builds artificial intelligence-driven tools to prevent problem gambling.
Jan 22, 2021NexImmune elects to launch initial public offering
Johns Hopkins University's oncology therapy developer NexImmune has filed to raise up to $86.3m in an IPO on the Nasdaq Global Market.
Jan 21, 2021Bolt Biotherapeutics charges to IPO stage
Novo and Pfizer are among the investors set to exit the Stanford spinout, which has set a $100m target for its initial public offering.
Jan 21, 2021Remynd boosts series B
The KU Leuven spinout has completed another tranche of funding for its series B round featuring investments from the university.
Jan 21, 2021NexImmune elects to launch initial public offering
Amgen and Pfizer-backed oncology therapy developer NexImmune has filed to raise up to $86.3m in an IPO on the Nasdaq Global Market.
Jan 21, 2021Volta plugs into $125m series D
Invenergy unit Energize Ventures returned for a series D round that lifted the electric vehicle charger provider's total equity funding to $200m.
Jan 21, 2021Bolt Biotherapeutics charges to IPO stage
Novo and Pfizer are among the investors set to exit the cancer therapy developer, which has set a $100m target for its initial public offering.
Jan 21, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
